Anti-IL-6/IL-6R antibodies and methods of use thereof

Details Anti-IL-6/IL-6R antibodies and methods of use thereof Anti-IL-6/IL-6R antibodies and methods of use thereof

2009-05-13

2011-10-11

Mertz, Prema (Department: 1646)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

C424S142100, C424S143100, C424S145100, C530S388100, C530S388150, C530S388220, C530S388230

Reexamination Certificate

active

08034344

ABSTRACT:
This invention provides fully human monoclonal antibodies that recognize the IL-6/IL-6R complex. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.

REFERENCES:
patent: 5618700 (1997-04-01), Novick et al.
patent: 5670373 (1997-09-01), Kishimoto
patent: 5817790 (1998-10-01), Tsuchiya et al.
patent: 5888510 (1999-03-01), Kishimoto et al.
patent: 5990282 (1999-11-01), Kishimoto
patent: 6083501 (2000-07-01), Miyata et al.
patent: 6261250 (2001-07-01), Phillips
patent: 6410691 (2002-06-01), Kishimoto
patent: 6419944 (2002-07-01), Tobinick
patent: 6428979 (2002-08-01), Kishimoto
patent: 6723319 (2004-04-01), Ito et al.
patent: 2004/0028681 (2004-02-01), Ito et al.
patent: 2005/0074821 (2005-04-01), Wild et al.
patent: 2005/0100550 (2005-05-01), Trikha et al.
patent: 2005/0238644 (2005-10-01), Mihara et al.
patent: 2006/0134113 (2006-06-01), Mihara
patent: 2006/0165696 (2006-07-01), Hideuki
patent: 2006/0188502 (2006-08-01), Giles-Komar et al.
patent: 2006/0240012 (2006-10-01), Sugimura et al.
patent: 2006/0251653 (2006-11-01), Okuda et al.
patent: 2006/0257407 (2006-11-01), Chen et al.
patent: 2006/0292147 (2006-12-01), Yoshizaki et al.
patent: 2007/0036785 (2007-02-01), Kishomoto et al.
patent: 2007/0036788 (2007-02-01), Sheriff et al.
patent: 2007/0098714 (2007-05-01), Nishimoto et al.
patent: 2007/0148169 (2007-06-01), Yoshizaki et al.
patent: 2007/0207153 (2007-09-01), Fuijoka et al.
patent: 2007/0243189 (2007-10-01), Yoshizaki et al.
patent: 2007/0280945 (2007-12-01), Stevens et al.
patent: 2007/0292420 (2007-12-01), Giles-Komar et al.
patent: 2008/0124325 (2008-05-01), Hiroaki
patent: 2008/0145367 (2008-06-01), Bove et al.
patent: 0504307 (1994-01-01), None
patent: 0325474 (1995-05-01), None
patent: 0409607 (1996-10-01), None
patent: 0791359 (1997-08-01), None
patent: 1536012 (2005-06-01), None
patent: 4325095 (1992-11-01), None
patent: 10066582 (1998-03-01), None
patent: WO 95/09873 (1995-04-01), None
patent: WO 96/11020 (1996-04-01), None
patent: WO 96/12503 (1996-05-01), None
patent: WO 98/42377 (1998-10-01), None
patent: WO 99/47170 (1999-09-01), None
patent: WO 00/10607 (2000-03-01), None
patent: WO 2006/119115 (2006-11-01), None
patent: WO 2007/066082 (2007-06-01), None
patent: WO 2007/076927 (2007-07-01), None
patent: WO 2007/143168 (2007-12-01), None
patent: WO 2008/019061 (2008-02-01), None
patent: WO 2008/021237 (2008-02-01), None
patent: WO 2008/065378 (2008-06-01), None
patent: WO 2008/065384 (2008-06-01), None
patent: WO 2008/071685 (2008-06-01), None
Gaillard, et al., “Identification of a Novel Antigenic Structure of the Human Receptor for Interleukin-6 Involved in the Interaction with the Glycoprotein 130 Chain, ” Immunology, vol. 89(1): 135-141 (1996).
Grube, et al., “Identification of a Regulatory Domain of the Interleukin-6 Receptor,” J. Biological Chemistry, vol. 269(32): 20791-797 (1994).
Mizuguchi et al., “Enhanced signal transduction by a directly fused protein of interleukin-6 and its receptor,” J Biosci Bioeng., vol. 91(3):299-304 (2001).
Taga et al, “Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130,” Cell, vol. 58(3):573-81 (1989).
U.S. Appl. No. 09/762,550 as deposited on Feb. 9, 2001 with the U.S. Patent and Trademark Office.

Affiliated with

Also associated with

Rating

Anti-IL-6/IL-6R antibodies and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-IL-6/IL-6R antibodies and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-IL-6/IL-6R antibodies and methods of use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4281254